Intellectual property rights are the bedrock of life-science innovation. But attacks on numerous fronts, from pervasive anti-patent myths to attempts to misuse march-in rights, now threaten to erode this foundation. Featuring leading experts in intellectual property policy and biotechnology, this panel will discuss what BIO stakeholders need to know about current policy debates surrounding IP rights, and emerging opportunities to make an impact through advocacy.